Answers are grounded in this paper and cite their sources.
Recent developments of new drugs' combinations are changing the treatment paradigm in hepatitis C virus infection. Due to the side effect profile of pegylated interferons, interferon-sparing regimens have become the main target in chronic hepatitis C treatment research. Recent proofs of concept studies have suggested that cure of chronic hepatitis C can be achieved without interferon. The purpose of this paper is to provide an overview of the clinical results recently reported for the treatment of hepatitis C virus infection with interferon-free regimens, focusing on the most promising new compounds and combinations.
No takes yet. Share an insight, caveat, or question.
González‐Moreno et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: